Status:
COMPLETED
Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management
Lead Sponsor:
Benha University
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Knee osteoarthritis is a very common joint condition that leads to pain, stiffness, and difficulty with daily activities, particularly in middle-aged and older adults. Many patients do not get adequat...
Eligibility Criteria
Inclusion
- Adults aged 45 to 75 years
- Radiographically confirmed knee osteoarthritis (Kellgren-Lawrence grade II-III)
- Persistent knee pain for at least 3 months despite oral non-steroidal anti-inflammatory drugs
- Ability to provide informed consent
Exclusion
- Prior intra-articular injection within the past 6 months
- Inflammatory arthritis (e.g., rheumatoid arthritis, gout)
- Advanced knee osteoarthritis (Kellgren-Lawrence grade IV)
- Active joint or systemic infection
- Bleeding disorder or anticoagulant use contraindicating injection
- Uncontrolled diabetes mellitus
- Known hypersensitivity to tenoxicam or triamcinolone acetonide
Key Trial Info
Start Date :
November 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07194135
Start Date
November 3 2024
End Date
April 30 2025
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha University Hospitals, Department of Orthopedics and Rheumatology
Banhā, Qalyubia Governorate, Egypt, 13511